MedTechVets Announces Veteran Placement Partnership with Insulet

Maria Artunduaga’s grandmother never smoked. However, like many members of her generation, she was exposed to second-hand cigarette smoke much of her life. When she developed chronic obstructive pulmonary disease (COPD), lung monitoring technologies were inadequate. Maria’s grandmother lived until age 90, but the last years of her life were exhausting and limiting. Going to mass once a week was all she could endure.

MedTechVets, a leading non-profit organization dedicated to supporting military veterans in transitioning into careers in the medical technology sector, proudly announces Mary McLoughlin will be consulting as Strategic Advisor effective July 1, 2024. With an extensive background in both healthcare policy and corporate leadership, Mary McLoughlin brings over 30 years of experience to MedTechVets. “As a former colleague, I have worked with Mary for 17 years and I know that she is intelligent, articulate and will provide strategic insight to help more veterans find careers with purpose in the Medical Technology Industry,” said Steve Mapa, President and Executive Director of MedTechVets.

Steve Mapa earned an engineering management degree at the U.S. Military Academy at West Point. He served in the Army during the first Gulf War, Operation Desert Storm, as a second lieutenant. After active duty, looking for work, he found his military leadership experience didn’t register with private sector employers. At the time, in the early 1990s, programs to help veterans shift to private sector positions didn’t exist. “It was really quite the challenge to transition and find a career with purpose,” Steve told me on the Medtech POV podcast.

In the newest episode of Medtech POV, Steve Mapa, President and Executive Director of MedTechVets, joins host Scott Whitaker to talk about his career in the United States Army and the medtech industry and the work his organization is doing to support veterans as they transition from active duty to a civilian career.

AdvaMed® released a statement in support of the bipartisan PREVENT DIABETES Act, which was marked up today in the House Energy and Commerce Health Subcommittee. The legislation, introduced by Reps. Diana DeGette (D-CO), Gus Bilirakis (R-FL), and Jason Crow (D-CO). It was also introduced in the U.S. Senate by Senators Mark Warner (D-VA) and Tim Scott (R-SC).

Get the latest on new policy updates and guidance for the clinical evaluation of medical devices.

Join us for this insightful webinar on the challenges and opportunities faced by women professionals in the life sciences industry.

Today, diabetes was front and center during a Senate HELP Committee hearing, prompting AdvaMed® President and CEO Scott Whitaker to release the following statement on the ways life-saving medical technology is critical in diabetes management: